[G23-31] Dalbavancin (acute bacterial skin and skin structure infections) – Addendum to Project A23-19
Last updated 15.02.2024
Project no.:
G23-31
Commission:
Commission awarded on 12.12.2023 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Health Economics
Topic:
Immune system and infections
Note:
If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The G-BA decides on the number of patients in the SHI target population.
DOI:
https://dx.doi.org/10.60584/G23-31
| Project no. | Title | Status |
|---|---|---|
| G23-19 | Dalbavancin (acute bacterial skin and skin structure infections, = 3 months) – Assessment according to §35a (para. 1c) Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2024-02-15 A G-BA decision was published.